Fogrel Sustained Release Tablet 300 mg (Sarpogrelate Hydrochloride)

Adult dose

Administer 300 mg of Sarpogrelate Hydrochloride sustained-release tablet orally once daily after meals. This drug should be taken as a whole without chewing or crushing.

This drug should not be administered to patients with bleeding. In conditions with a high risk of bleeding, such as hemophilia or gastrointestinal ulcers, bleeding may worsen. It is safer for women who are pregnant or may become pregnant to not take this drug, as animal studies have shown harmful effects on the fetus. Women during menstruation or patients with a tendency for bleeding should use this drug cautiously due to the risk of exacerbating bleeding. Patients taking anticoagulants or antiplatelet agents should be aware that the risk of bleeding may increase when using this drug together. Elderly patients or those with severely impaired kidney function should be cautious with this drug, as its excretion may be difficult, raising the risk of side effects. Various side effects such as rash, dyspepsia, diarrhea, headache, and cough may occur during treatment; therefore, if any abnormal symptoms arise, it is important to consult a doctor immediately. Regular blood tests and liver function tests are important to monitor for possible side effects of this drug. It is preferable for pregnant or breastfeeding women to avoid this drug, and if necessary, it is recommended to stop breastfeeding. Safety in children has not been established, so it is generally not used in pediatric patients. This drug should be stored out of reach of children, and transferring it to another container should be avoided to help maintain its quality.

Serious side effects

Rash, gastrointestinal bleeding (hematemesis and melena), intracranial hemorrhage, subcutaneous hemorrhage, agranulocytosis, anemia, thrombocytopenia, leukopenia, acute hepatitis, liver impairment, jaundice, palpitations, dyspnea, myocardial infarction, angina, cerebral infarction, stroke, gallbladder cancer, fracture, gastric perforation, intestinal obstruction, exacerbation of Crohn's disease, gastric perforation, hematemesis

Mild side effects

• Nasopharyngitis
• conjunctivitis
• upper respiratory infection
• dyspepsia
• constipation
• diarrhea
• gastritis
• gastrointestinal dysfunction
• hypoglycemia
• decreased appetite

This drug should be stored in a tightly closed container to protect it from air and moisture. The storage temperature should be maintained between 1 and 30 degrees Celsius.

Appearance

White oblong film-coated tablet

Package unit

30 tablets/bottle, 100 tablets/bottle